Robert Goldstein
Pain Medicine · Charlottesville, VANPI 1346319977
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Tersera Therapeutics LLC at 37.4% of the total. 2025 is the largest year on record at $2,975, 3.7 times the $814 reported in 2019.
Across 63 payments — averaging $122.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tersera Therapeutics LLC$3K
- Medtronic$2K
- Rivanna Medical, Inc$1K
- SPR Therapeutics, Inc$741
- MML US, Inc.$334
- Abbott$141
- plus $218 from 3 others
What the payments were for
- Consulting fees$3,71048%
- Travel & lodging$87611%
- Food & beverage$3,12841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tersera Therapeutics LLC | 10 | $2,885 |
| Medtronic(2 entities) | 33 | $2,345 |
| Rivanna Medical, Inc | 1 | $1,050 |
| SPR Therapeutics, Inc | 8 | $741 |
| MML US, Inc. | 5 | $334 |
| Abbott | 2 | $141 |
| Boston Scientific | 2 | $120 |
| Bioventus LLC | 1 | $81 |
| Vertos Medical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRIALT$2,885
- Accuro$1,050
- OSTEOCOOL RF ABLATION SYSTEM$796
- SPRINT PNS System$529
- INTELLIS ADAPTIVESTIM$518
- ReActiv8$315
- INCEPTIV$160
- S-Series SCS Leads$133
- SYNCHROMEDII$120
- SPECTRA WAVEWRITER$107
How this compares
$7,714 in reported general payments places this provider in the 80th percentile of 150 pain medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 11 | $214 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Charlottesville
- Lynn KohanCharlottesville$30K
- Christina ShinCharlottesville$18K
- Matthew HollandCharlottesville$9K
- Logan KinchCharlottesville$8K
- Richard MessingerCharlottesville$4K
- Rasheed SiddiquiCharlottesville$4K
- Xiaoying ZhuCharlottesville$3K
- Chheany UngRoanoke$198K
- Daniel KendallMc Lean$100K
- Steven GershonVirginia Beach$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.